IONS- Ionis Pharmaceuticals, Inc.

Insider activity in IONS over the last quarter tilts toward selling: insiders offloaded a net 196,094 shares worth roughly $15.4M.

Classified under Biotechnology (Health Care sector), IONS's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Berthelsen Spencer R	156.0K	$8.82M	-
CEO	Monia Brett P	99.9K	$5.65M	-
CFO	Hougen Elizabeth L	82.7K	$4.68M	-
VP	Geary Richard S	74.4K	$4.21M	-
VP	Schneider Eugene	69.7K	$3.94M	-

Buys and sells only

10 filings · page 17

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 6, 2023	Schneider Eugene64	EVP, Chf Clinical Develop Ofcr	Sell	1,413	$40.67	$57,464.17	-5.4%	-13.1%	+21.3%
Feb 6, 2023	O'Neil Patrick R.57	EVP CLO &General Counsel	Sell	1,920	$40.86	$78,460.42	-4.4%	-13.1%	+21.3%
Feb 6, 2023	Hougen Elizabeth L55	EVP, Finance &CFO	Sell	2,079	$40.59	$84,392.22	-2.7%	-13.1%	+21.3%
Feb 6, 2023	Geary Richard S65	EVP, Chief Development Officer	Sell	1,920	$40.66	$78,070.08	-2.6%	-13.1%	+21.3%
Feb 6, 2023	Cadoret-Manier Onaiza53	EVP, Chf Gl Pdt Str &Oper Ofc	Sell	1,451	$40.66	$58,996.93	-6.4%	-13.1%	+21.3%
Feb 6, 2023	Bennett C Frank64	EVP, Chief Scientific Officer	Sell	1,813	$40.57	$73,560.30	-2.5%	-13.1%	+21.3%
Feb 6, 2023	Monia Brett P60	Chief Executive Officer	Sell	24,651	$40.69	$1,003,152.72	-14.5%	-13.1%	+21.3%
Jan 31, 2023	O'Neil Patrick R.57	EVP CLO &General Counsel	Sell	9,000	$39.56	$356,071.95	-9.7%	-10.5%	+28.9%
Jan 18, 2023	Swayze Eric63	EVP Research	Sale+OE	5,631	$39.74	$223,799.59	-15.8%	-8.6%	+27.2%
Jan 18, 2023	Schneider Eugene64	EVP, Chf Clinical Develop Ofcr	Sale+OE	4,752	$39.57	$188,051.85	-17.5%	-8.6%	+27.2%